Related references
Note: Only part of the references are listed.Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle
Roselyne Castonguay et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice
Jennifer A. Tinklenberg et al.
HUMAN MOLECULAR GENETICS (2018)
LOCALLY ACTING ACE-083 INCREASES MUSCLE VOLUME IN HEALTHY VOLUNTEERS
Chad E. Glasser et al.
MUSCLE & NERVE (2018)
Transcriptional profiling reveals extraordinary diversity among skeletal muscle tissues
Erin E. Terry et al.
ELIFE (2018)
Inhibition of the Activin Receptor Type-2B Pathway Restores Regenerative Capacity in Satellite Cell-Depleted Skeletal Muscle
Luigi Formicola et al.
FRONTIERS IN PHYSIOLOGY (2018)
Preliminary phase 2 results for ACE-083, local muscle therapeutic, in patients with CMT1 and CMTX
M. Shy et al.
NEUROMUSCULAR DISORDERS (2018)
Results for a dose-escalation phase 2 study to evaluate ACE-083, a local muscle therapeutic, in patients with facioscapulohumeral muscular dystrophy
J. Statland et al.
NEUROMUSCULAR DISORDERS (2018)
Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone
Andrea Iskenderian et al.
SKELETAL MUSCLE (2018)
AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD
Carlee R. Giesige et al.
JCI INSIGHT (2018)
MYOSTATIN INHIBITOR ACE-031 TREATMENT OF AMBULATORY BOYS WITH DUCHENNE MUSCULAR DYSTROPHY: RESULTS OF A RANDOMIZED, PLACEBO- CONTROLLED CLINICAL TRIAL
Craig Campbell et al.
MUSCLE & NERVE (2017)
Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease
Justin L. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
Virginie Mariot et al.
NATURE COMMUNICATIONS (2017)
Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model
Darko Bosnakovski et al.
NATURE COMMUNICATIONS (2017)
Activin A more prominently regulates muscle mass in primates than does GDF8
Esther Latres et al.
NATURE COMMUNICATIONS (2017)
Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting
Teresa A. Zimmers et al.
BASIC RESEARCH IN CARDIOLOGY (2017)
Supraphysiological levels of GDF11 induce striated muscle atrophy
David W. Hammers et al.
EMBO MOLECULAR MEDICINE (2017)
Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding
Senem Aykul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Agonists and Antagonists of TGF-β Family Ligands
Chenbei Chang
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Management of Charcot-Marie-Tooth disease: improving long-term care with a multidisciplinary approach
Donald McCorquodale et al.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2016)
GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration
Marc A. Egerman et al.
CELL METABOLISM (2015)
A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
Jerry R. Mendell et al.
MOLECULAR THERAPY (2015)
Satellite cells from dystrophic muscle retain regenerative capacity
Luisa Boldrin et al.
STEM CELL RESEARCH (2015)
Satellite cells in human skeletal muscle plasticity
Tim Snijders et al.
FRONTIERS IN PHYSIOLOGY (2015)
Wnt/β-catenin controls follistatin signalling to regulate satellite cell myogenic potential
Andrew E. Jones et al.
SKELETAL MUSCLE (2015)
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
Timo Rath et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2015)
Matrigel: From discovery and ECM mimicry to assays and models for cancer research
Gabriel Benton et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Inhibition of Activin A Ameliorates Skeletal Muscle Injury and Rescues Contractile Properties by Inducing Efficient Remodeling in Female Mice
Benjamin C. Yaden et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Sue C. Bodine et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients
Yetrib Hathout et al.
HUMAN MOLECULAR GENETICS (2014)
Heparan sulfate proteoglycan as a cell-surface endocytosis receptor
Helena C. Christianson et al.
MATRIX BIOLOGY (2014)
TGFβ and BMP signaling in skeletal muscle: potential significance for muscle-related disease
Roberta Sartori et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Follistatin: A Novel Therapeutic for the Improvement of Muscle Regenerations
Benjamin C. Yaden et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Mechanisms regulating skeletal muscle growth and atrophy
Stefano Schiaffino et al.
FEBS JOURNAL (2013)
Muscle type and fiber type specificity in muscle wasting
Stefano Ciciliot et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
An Engineered Human Follistatin Variant: Insights into the Pharmacokinetic and Pharmocodynamic Relationships of a Novel Molecule with Broad Therapeutic Potential
Amita Datta-Mannan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease
Robert Fledrich et al.
BRITISH MEDICAL BULLETIN (2012)
Fc-fusion proteins: new developments and future perspectives
Daniel M. Czajkowsky et al.
EMBO MOLECULAR MEDICINE (2012)
Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification
Michael N. Wosczyna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
Catherine E. Winbanks et al.
JOURNAL OF CELL BIOLOGY (2012)
Inhibition of myostatin reverses muscle fibrosis through apoptosis
Zhao Bo Li et al.
JOURNAL OF CELL SCIENCE (2012)
Follistatin Improves Skeletal Muscle Healing after Injury and Disease through an Interaction with Muscle Regeneration, Angiogenesis, and Fibrosis
Jinhong Zhu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Extracellular Movement of Signaling Molecules
Patrick Mueller et al.
DEVELOPMENTAL CELL (2011)
Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands
Craig A. Harrison et al.
GROWTH FACTORS (2011)
Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle
Akiyoshi Uezumi et al.
JOURNAL OF CELL SCIENCE (2011)
Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists
Christopher C. Rider et al.
BIOCHEMICAL JOURNAL (2010)
Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type
Samuel M. Cadena et al.
JOURNAL OF APPLIED PHYSIOLOGY (2010)
Regulation of Muscle Mass by Follistatin and Activins
Se-Jin Lee et al.
MOLECULAR ENDOCRINOLOGY (2010)
Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle
Akiyoshi Uezumi et al.
NATURE CELL BIOLOGY (2010)
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis
Aaron W. B. Joe et al.
NATURE CELL BIOLOGY (2010)
Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene
Lauren Snider et al.
PLOS GENETICS (2010)
Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin
Helene Gilson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates
Janaiah Kota et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Bone morphogenetic protein-9 is a circulating vascular quiescence factor
Laurent David et al.
CIRCULATION RESEARCH (2008)
Identification of a novel pool of extracellular pro-myostatin in skeletal muscle
Sarah B. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Myostatin directly regulates skeletal muscle fibrosis
Zhao Bo Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors
Amanda M. Haidet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Lack of myostatin results in excessive muscle growth but impaired force generation
Helge Amthor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Facioscapulohumeral muscular dystrophy
Rabi Tawil et al.
MUSCLE & NERVE (2006)
Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins
Yisrael Sidis et al.
ENDOCRINOLOGY (2006)
Differential distribution of follistatin isoforms: Application of a new FS315-specific immunoassay
AL Schneyer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Identification of ubiquitin ligases required for skeletal muscle atrophy
SC Bodine et al.
SCIENCE (2001)
Regulation of myostatin activity and muscle growth
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
